RIC: Research Interest Comparator

Jennifer Giltnane, researcher
MD/PhD Student
Affiliation: Yale Univ. Pathology Dept.
Office: BML 169
Phone #: 203-785-2321
Fax: not provided
Email: jennifer.giltnane@yale.edu
Home Page: www.tissuearray.org
Lab: David Rimm
New This Month | New This Year | Abstract | Selected Publications | RIC Statistics Results - FULL MEDLINE:

Quantitative proteomics?
M Mann
Nat Biotechnol 1999 Oct; 17(10)954-5.
Score: 0.645
Quantitative proteomics.
Michael W Linscheid
Anal Bioanal Chem 2005 Jan; 381(1)64-6.
Score: 0.645
AQUA DESTILLATA -- AQUA PRO INIECTIONE. (2ND. REPORT).
H LIST
Drugs Made Ger 1963 Sep; 18()168-72.
Score: 0.635
Proteomics. Proteomics in genomeland.
S Fields
Science 2001 Feb; 291(5507)1221-4.
Score: 0.632
Quantitative determination of expression of the prostate cancer protein alpha-methylacyl-CoA racemase using automated quantitative analysis (AQUA): a novel paradigm for automated and continuous biomarker measurements.
Mark A Rubin ... David L Rimm
Am J Pathol 2004 Mar; 164(3)831-40.
Score: 0.628
Automated subcellular localization and quantification of protein expression in tissue microarrays.
Robert L Camp ... David L Rimm
Nat Med 2002 Nov; 8(11)1323-7.
Score: 0.620
ErbB family of receptors include 4 different receptors, each of which, with the exception of ErbB 2, has a number of ligands.
F Caponigro
Curr Drug Targets 2005 May; 6(3)241-2.
Score: 0.617
Growth signaling in breast cancer cells: outcomes and promises of proteomics.
Eric Adriaenssens ... Hubert Hondermarck
Biochem Pharmacol 2002 Sep; 64(5-6)797-803.
Score: 0.599
Microdissection, microarrays and proteomics: a new approach to the study of eye diseases.
Vassiliki Poulaki
Graefes Arch Clin Exp Ophthalmol 2003 Jul; 241(7)527-8.
Score: 0.589
Microarrays go live--new prospects for proteomics.
B Blagoev ... A Pandey
Trends Biochem Sci 2001 Nov; 26(11)639-41.
Score: 0.589
Proteomics.
Nat Biotechnol 2000 Oct; 18 Suppl()IT45-6.
Score: 0.587
The EGF/ErbB receptor family and apoptosis.
Andrew J Danielsen ... Nita J Maihle
Growth Factors 2002 Mar; 20(1)1-15.
Score: 0.570
Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome.
Robert L Camp ... David L Rimm
Cancer Res 2003 Apr; 63(7)1445-8.
Score: 0.565
Targeting ErbB receptor signaling: a pan-ErbB approach to cancer.
Carolyn D Britten
Mol Cancer Ther 2004 Oct; 3(10)1335-42.
Score: 0.561
Proteomics. Proteomics 2.0: the view ahead.
R F Service
Science 2001 Dec; 294(5549)2076.
Score: 0.558
Quantitative analysis of proteomics using data mining. An automated system for constructing assays quickly and precisely.
Chia-Yu Yen ... Mark W Duncan
IEEE Eng Med Biol Mag 2005 May-Jun; 24(3)67-72.
Score: 0.552
Serum proteomics for BRCA1-associated breast cancer.
Funda Meric-Bernstam
Ann Surg Oncol 2004 Oct; 11(10)883-4.
Score: 0.549
Design, construction, and use of tissue microarrays.
Stephen M Hewitt
Methods Mol Biol 2004 ; 264()61-72.
Score: 0.544
Aqua vita.
P McCrory
Br J Sports Med 2005 Feb; 39(2)63.
Score: 0.544
The ErbB signaling network is coordinately expressed and activated in the mouse prostate.
Yun Zhu ... Frank E Jones
Prostate 2004 Jun; 60(1)68-75.
Score: 0.532
Proteomics in reproductive research: the potential importance of proteomics to research in reproduction.
I A Brewis
Hum Reprod 1999 Dec; 14(12)2927-9.
Score: 0.530
Proteomics. A proteomics upstart tries to outrun the competition.
R F Service
Science 2001 Dec; 294(5549)2079-80.
Score: 0.530
Quantitative proteomics goes global.
Z Ziegler
Anal Chem 2001 May; 73(9)251A.
Score: 0.526
Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Malini Harigopal ... Harriet M Kluger
Clin Cancer Res 2005 Jun; 11(11)4083-9.
Score: 0.526
Proteomics of breast cancer for marker discovery and signal pathway profiling.
H Hondermarck ... J P Peyrat
Proteomics 2001 Oct; 1(10)1216-32.
Score: 0.522
In situ synthesis of oligonucleotide microarrays.
Xiaolian Gao ... Xiaochuan Zhou
Biopolymers 2004 Apr; 73(5)579-96.
Score: 0.522
ErbB receptors: directing key signaling networks throughout life.
Thomas Holbro ... Nancy E Hynes
Annu Rev Pharmacol Toxicol 2004 ; 44()195-217.
Score: 0.519
Proteomics of breast cancer: outcomes and prospects.
Ikram El Yazidi-Belkoura ... Hubert Hondermarck
Technol Cancer Res Treat 2002 Aug; 1(4)287-96.
Score: 0.518
[Advances in cancer proteomics study]
Zhu-Chu Chen
Ai Zheng 2004 Feb; 23(2)113-7.
Score: 0.515
Targeting ligand cleavage to inhibit the ErbB pathway in cancer.
Bin-Bing S Zhou
Ann N Y Acad Sci 2005 Nov; 1059()56-60.
Score: 0.515
Implications of new proteomics strategies for biology and medicine.
Bruno Domon ... Samuel Broder
J Proteome Res 2004 Mar-Apr; 3(2)253-60.
Score: 0.515
Protein microarrays: molecular profiling technologies for clinical specimens.
Virginia Espina ... Lance A Liotta
Proteomics 2003 Nov; 3(11)2091-100.
Score: 0.514
Enhancing the antitumor activity of ErbB blockade with histone deacetylase (HDAC) inhibition.
Prakash Chinnaiyan ... Paul M Harari
Int J Cancer 2006 Feb; 118(4)1041-50.
Score: 0.511
NIH standards in proteomics workshop. Proteomics repositories up for debate.
Katie Cottingham
J Proteome Res 2005 Mar-Apr; 4(2)220.
Score: 0.506
Tissue microarrays: bridging the gap between research and the clinic.
Till Braunschweig ... Stephen M Hewitt
Expert Rev Proteomics 2005 Jun; 2(3)325-36.
Score: 0.506
Functional proteomics of breast cancer for signal pathway profiling and target discovery.
Hubert Hondermarck ... Jérôme Lemoine
J Mammary Gland Biol Neoplasia 2002 Oct; 7(4)395-405.
Score: 0.505
Proteomics approaches to uncover the repertoire of circulating biomarkers for breast cancer.
Bong Kyung Shin ... Samir Hanash
J Mammary Gland Biol Neoplasia 2002 Oct; 7(4)407-13.
Score: 0.505
Breast cancer proteomics using two-dimensional electrophoresis: studying the breast cancer proteome.
Miriam V Dwek ... Sarah L Rawlings
Methods Mol Med 2006 ; 120()231-43.
Score: 0.504
CI-1033, an irreversible pan-erbB receptor inhibitor and its potential application for the treatment of breast cancer.
Lee F Allen ... Peter F Lenehan
Semin Oncol 2003 Oct; 30(5 Suppl 16)65-78.
Score: 0.501
Tissue microarrays.
Iqbal S Shergill ... Manit Arya
Expert Rev Mol Diagn 2004 Jul; 4(4)421-3.
Score: 0.499
Tissue microarrays without cores.
David L Rimm
Nat Methods 2005 Jul; 2(7)492-3.
Score: 0.499
Proteomics in translational cancer research: toward an integrated approach.
Julio E Celis ... Pavel Gromov
Cancer Cell 2003 Jan; 3(1)9-15.
Score: 0.497
Opportunities for nanotechnology-based innovation in tissue proteomics.
David H Geho ... Lance A Liotta
Biomed Microdevices 2004 Sep; 6(3)231-9.
Score: 0.497
Using protein microarrays to study cancer.
Arun Sreekumar ... Arul M Chinnaiyan
Biotechniques 2002 Dec; Suppl()46-53.
Score: 0.495
The ErbB signaling network: receptor heterodimerization in development and cancer.
M A Olayioye ... N E Hynes
EMBO J 2000 Jul; 19(13)3159-67.
Score: 0.492
Technology insight: Identification of biomarkers with tissue microarray technology.
Jena M Giltnane ... David L Rimm
Nat Clin Pract Oncol 2004 Dec; 1(2)104-11.
Score: 0.490
Potential benefits of the irreversible pan-erbB inhibitor, CI-1033, in the treatment of breast cancer.
Lee F Allen ... David W Fry
Semin Oncol 2002 Jun; 29(3 Suppl 11)11-21.
Score: 0.489
Protein microarrays as tools for functional proteomics.
Joshua LaBaer ... Niroshan Ramachandran
Curr Opin Chem Biol 2005 Feb; 9(1)14-9.
Score: 0.487
Mass spectrometric approaches to quantitative proteomics.
Salvatore Sechi
Contrib Nephrol 2004 ; 141()59-78.
Score: 0.487
A toothbrush supplement--the "Aqua Pik.
Dent News (Lond) 1968 Jul; 5(7)28.
Score: 0.486
Localization and modulation of ErbB receptor tyrosine kinases.
K L Carraway ... C Sweeney
Curr Opin Cell Biol 2001 Apr; 13(2)125-30.
Score: 0.485
Proteomic analysis of human breast cancer tissue with laser-capture microdissection and reverse-phase protein microarrays.
Stacy M Cowherd ... Lance A Liotta
Clin Breast Cancer 2004 Dec; 5(5)385-92.
Score: 0.485
Microarrays.
Jason D Christie
Crit Care Med 2005 Dec; 33(12 Suppl)S449-52.
Score: 0.482
Breast tissue microarrays.
Robert J Springall ... Cheryl E Gillett
Methods Mol Med 2006 ; 120()43-50.
Score: 0.481
Proteomics' new order.
Nature 2005 Sep; 437(7056)169-70.
Score: 0.479
Proteomics.
A Persidis
Nat Biotechnol 1998 Apr; 16(4)393-4.
Score: 0.479
Proteomics.
Helmut E Meyer
Anal Bioanal Chem 2003 Aug; 376(7)945.
Score: 0.479
Proteomics.
D D Banker
Indian J Med Sci 2002 Jan; 56(1)22-4.
Score: 0.479
Proteomics, transcriptomics: what's in a name?
Nature 1999 Dec; 402(6763)715.
Score: 0.479
The promise of proteomics.
Nature 1999 Dec; 402(6763)703.
Score: 0.479
Proteomics.
Michael W Stanley
Am J Clin Pathol 2002 Dec; 118(6)825-6.
Score: 0.479
Proteomics in China.
Fuchu He
Proteomics 2006 Jan; 6(2)397-403.
Score: 0.479
The ErbB receptor tyrosine family as signal integrators.
N E Hynes ... A Badache
Endocr Relat Cancer 2001 Sep; 8(3)151-9.
Score: 0.477
Use of laser capture microdissection, cDNA microarrays, and tissue microarrays in advancing our understanding of prostate cancer.
M A Rubin
J Pathol 2001 Sep; 195(1)80-6.
Score: 0.472
The role of ErbB inhibitors in trastuzumab resistance.
Kathy D Miller
Oncologist 2004 ; 9 Suppl 3()16-9.
Score: 0.464
Failed to fetch article title! Article may not be available.
Score: 0.463
Sensitive quantitative nucleic acid detection using oligonucleotide microarrays.
Arnold Vainrub ... B Montgomery Pettitt
J Am Chem Soc 2003 Jul; 125(26)7798-9.
Score: 0.462
DNA microarrays in breast cancer: the promise of personalised medicine.
Sridhar Ramaswamy ... Charles M Perou
Lancet 2003 May; 361(9369)1576-7.
Score: 0.461
The ErbB receptors and their role in cancer progression.
Thomas Holbro ... Nancy E Hynes
Exp Cell Res 2003 Mar; 284(1)99-110.
Score: 0.460
Proteomics.
John T Stults ... David Arnott
Methods Enzymol 2005 ; 402()245-89.
Score: 0.458
High-throughput proteomics using antibody microarrays.
Christer Wingren ... Carl A K Borrebaeck
Expert Rev Proteomics 2004 Oct; 1(3)355-64.
Score: 0.458
NRG-3 in human breast cancers: activation of multiple erbB family proteins.
M M Hijazi ... C R King
Int J Oncol 1998 Nov; 13(5)1061-7.
Score: 0.456
Current strategies for quantitative proteomics.
Thomas P Conrads ... Van M Hoang
Adv Protein Chem 2003 ; 65()133-59.
Score: 0.456
Applications of microarrays to histopathology.
M van de Rijn ... C B Gilks
Histopathology 2004 Feb; 44(2)97-108.
Score: 0.456
Tissue microarrays.
Ronald Simon ... Guido Sauter
Methods Mol Med 2004 ; 97()377-89.
Score: 0.455
The EGF receptor family as therapeutic targets in breast cancer.
Mark A Lemmon
Breast Dis 2003 ; 18()33-43.
Score: 0.455
Proteomics of TGF-beta signaling and its impact on breast cancer.
Serhiy Souchelnytskyi
Expert Rev Proteomics 2005 Dec; 2(6)925-35.
Score: 0.455
Tissue microarrays for hypothesis generation.
Ethan Dmitrovsky
J Natl Cancer Inst 2004 Feb; 96(4)248-9.
Score: 0.455
Tissue microarrays: what will they bring to molecular and anatomic pathology?
H Moch ... G Sauter
Adv Anat Pathol 2001 Jan; 8(1)14-20.
Score: 0.455
Tissue microarrays meet cytopathology.
Lukas Bubendorf
Acta Cytol 2006 Mar-Apr; 50(2)121-2.
Score: 0.455
Beyond the genome to tissue proteomics.
L A Liotta ... E F Petricoin
Breast Cancer Res 2000 ; 2(1)13-4.
Score: 0.453
Effect of epidermal growth factor receptor expression level on survival in patients with epithelial ovarian cancer.
Amanda Psyrri ... Meletios A Dimopoulos
Clin Cancer Res 2005 Dec; 11(24 Pt 1)8637-43.
Score: 0.451
Unsupervised imaging, registration and archiving of tissue microarrays.
Wenjin Chen ... Michael Reiss
Proc AMIA Symp 2002 ; ()136-9.
Score: 0.451
Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma.
Kyle A Divito ... Harriet M Kluger
Cancer Res 2004 Dec; 64(23)8773-7.
Score: 0.451
Double-differential PCR for gene dosage estimation of erbB oncogenes in benign and cancer tissues and comparison to cellular DNA content.
B Brandt ... G Assmann
Gene 1995 Jun; 159(1)29-34.
Score: 0.449
Specificity within the EGF family/ErbB receptor family signaling network.
D J Riese ... D F Stern
Bioessays 1998 Jan; 20(1)41-8.
Score: 0.447
Microarrays in cancer: research and applications.
Michael F Ochs ... Andrew K Godwin
Biotechniques 2003 Mar; Suppl()4-15.
Score: 0.447
Prediction of cancer outcome with microarrays.
Andrew H S Lee
Lancet 2005 May 14-20; 365(9472)1685; author reply 1686.
Score: 0.447
Expression of erbB/HER receptors, heregulin and P38 in primary breast cancer using quantitative immunohistochemistry.
F J Esteva ... S S Bacus
Pathol Oncol Res 2001 ; 7(3)171-7.
Score: 0.446
Advocating for aqua therapy.
Ruth Rowland Alteneder ... Catherine Hornbeck
AWHONN Lifelines 2003 Oct-Nov; 7(5)445-9.
Score: 0.444
[Let us talk about Aqua Pik]
Dent Cadmos 1967 Oct; 35(10)1413-21.
Score: 0.444
Editorial: The aqua regia of ecumenicalism.
I H Page
J Lab Clin Med 1975 Apr; 85(4)527-30.
Score: 0.444
Proteomics research aids cancer diagnosis and treatment.
Oncology (Williston Park) 2003 Jun; 17(6)794, 814.
Score: 0.444
Functional proteomics analysis of GTPase signaling networks.
G Alton ... J K Westwick
Methods Enzymol 2001 ; 332()300-16.
Score: 0.444
Proteomics and cancer: running before we can walk?
Erika Check
Nature 2004 Jun; 429(6991)496-7.
Score: 0.444
The management of in situ breast cancer.
F E Gump
Compr Ther 1992 Jun; 18(6)1-4.
Score: 0.443
Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis.
Agnieszka K Witkiewicz ... Celina G Kleer
Cancer Epidemiol Biomarkers Prev 2005 Jun; 14(6)1418-23.
Score: 0.443
Proteomics approaches to elucidation of signal transduction pathways.
Jasminka Godovac-Zimmermann ... Larry R Brown
Curr Opin Mol Ther 2003 Jun; 5(3)241-9.
Score: 0.442
Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
Joseph N Contessa ... Rupert K Schmidt-Ullrich
Breast Cancer Res Treat 2006 Jan; 95(1)17-27.
Score: 0.442
Signal transduction and oncogenesis by ErbB/HER receptors.
Mina D Marmor ... Yosef Yarden
Int J Radiat Oncol Biol Phys 2004 Mar; 58(3)903-13.
Score: 0.441
Prognostic relevance of aberrations in the erbB oncogenes from breast, ovarian, oral and lung cancers: double-differential polymerase chain reaction (ddPCR) for clinical diagnosis.
B Brandt ... K S Zänker
Gene 1995 Jun; 159(1)35-42.
Score: 0.441
Mutation analysis of cancer using automated sequencing.
Amanda Strickson ... Carrie Fidler
Methods Mol Med 2002 ; 68()171-7.
Score: 0.437
The molecular make-up of a tumour: proteomics in cancer research.
Walter Kolch ... Andrew R Pitt
Clin Sci (Lond) 2005 May; 108(5)369-83.
Score: 0.437
Analysis of prostate cancer by proteomics using tissue specimens.
Alvin Y Liu ... Deborah L Diamond
J Urol 2005 Jan; 173(1)73-8.
Score: 0.437
Trafficking of the ErbB receptors and its influence on signaling.
H Steven Wiley
Exp Cell Res 2003 Mar; 284(1)78-88.
Score: 0.436
Lipopolysaccharide stimulation of the human neutrophil: an analysis of changes in gene transcription and protein expression by oligonucleotide microarrays and proteomics.
Michael B Fessler ... G Scott Worthen
Chest 2002 Mar; 121(3 Suppl)75S-76S.
Score: 0.435
New targets for therapy in breast cancer: small molecule tyrosine kinase inhibitors.
Nancy U Lin ... Eric P Winer
Breast Cancer Res 2004 ; 6(5)204-10.
Score: 0.435
The Proteomics Identifications Database (PRIDE) and the ProteomExchange Consortium: making proteomics data accessible.
Henning Hermjakob ... Rolf Apweiler
Expert Rev Proteomics 2006 Feb; 3(1)1-3.
Score: 0.434
Yeast microarrays for genome wide parallel genetic and gene expression analysis.
D A Lashkari ... R W Davis
Proc Natl Acad Sci U S A 1997 Nov; 94(24)13057-62.
Score: 0.434
[Targeting epidermal growth factor receptor in cancer of the breast]
Véronique Diéras ... Patricia de Cremoux
Bull Cancer 2003 Nov; 90 Spec No()S257-62.
Score: 0.433
Blasting into the microworld of tissue proteomics: a new window on cancer.
David H Geho ... Lance A Liotta
Clin Cancer Res 2004 Feb; 10(3)825-7.
Score: 0.433
Array technology and proteomics in autoimmune diseases.
Veit Krenn ... Karl Skriner
Pathol Res Pract 2004 ; 200(2)95-103.
Score: 0.432
Microarrays and breast cancer clinical studies: forgetting what we have not yet learnt.
Ahmed Ashour Ahmed ... James D Brenton
Breast Cancer Res 2005 ; 7(3)96-9.
Score: 0.431
Conference report--protein microarrays in cancer and autoimmunity: tiny spots light up highlights of the ABRF 2004--integrating technologies in proteomics and genomics; February 28-March 2, 2004; Portland, Oregon.
Sara M Mariani
MedGenMed 2004 ; 6(2)24.
Score: 0.430
Dimensionality is the issue: use of photoaptamers in protein microarrays.
Helen Petach ... Larry Gold
Curr Opin Biotechnol 2002 Aug; 13(4)309-14.
Score: 0.430
Subcellular localization and protein levels of cyclin-dependent kinase inhibitor p27 independently predict for survival in epithelial ovarian cancer.
Amanda Psyrri ... Meletios A Dimopoulos
Clin Cancer Res 2005 Dec; 11(23)8384-90.
Score: 0.429
The role of ubiquitylation in signaling by growth factors: implications to cancer.
Keren Shtiegman ... Yosef Yarden
Semin Cancer Biol 2003 Feb; 13(1)29-40.
Score: 0.428
Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis.
Amanda Psyrri ... Barbara Ann Burtness
Clin Cancer Res 2005 Aug; 11(16)5856-62.
Score: 0.427
Evaluating the expression and prognostic value of TRAIL-R1 and TRAIL-R2 in breast cancer.
Mary M McCarthy ... Harriet M Kluger
Clin Cancer Res 2005 Jul; 11(14)5188-94.
Score: 0.427
Signaling through ERBB receptors: multiple layers of diversity and control.
Carmen M Warren ... Ralf Landgraf
Cell Signal 2006 Jul; 18(7)923-33.
Score: 0.427
Advances in quantitative proteomics using stable isotope tags.
Mark R Flory ... Ruedi Aebersold
Trends Biotechnol 2002 Dec; 20(12 Suppl)S23-9.
Score: 0.427
ADAM proteases, ErbB pathways and cancer.
Bin-Bing S Zhou ... Peggy A Scherle
Expert Opin Investig Drugs 2005 Jun; 14(6)591-606.
Score: 0.426
Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage.
C Sweeney ... K L Carraway
Oncogene 2000 Nov; 19(49)5568-73.
Score: 0.425
Automated quantitative immunochemical analysis of human immunoglobulins.
H Markowitz ... A R Tschida
Clin Chem 1972 Nov; 18(11)1364-7.
Score: 0.425
Cytomics and location proteomics: automated interpretation of subcellular patterns in fluorescence microscope images.
Robert F Murphy
Cytometry A 2005 Sep; 67(1)1-3.
Score: 0.424
Mass spectrometry-based quantitative proteomics.
Albert J R Heck ... Jeroen Krijgsveld
Expert Rev Proteomics 2004 Oct; 1(3)317-26.
Score: 0.424
[DNA microarrays and papillary thyroid carcinoma gene expression profile]
Barbara Jarzab ... Dariusz Lange
Endokrynol Pol 2005 May-Jun; 56(3)293-301.
Score: 0.424
Proteomics in gerontological research.
Christian Schöneich
Exp Gerontol 2003 May; 38(5)473-81.
Score: 0.423
From genomics to proteomics.
Mike Tyers ... Matthias Mann
Nature 2003 Mar; 422(6928)193-7.
Score: 0.423
A proteomics approach to find a new breast cancer-specific antigenic marker.
R Kobayashi
Clin Cancer Res 2001 Nov; 7(11)3325-7.
Score: 0.422
Update on HER-2 as a target for cancer therapy: intracellular signaling pathways of ErbB2/HER-2 and family members.
M A Olayioye
Breast Cancer Res 2001 ; 3(6)385-9.
Score: 0.422
Targeting ligand-activated ErbB2 signaling inhibits breast and prostate tumor growth.
David B Agus ... Mark X Sliwkowski
Cancer Cell 2002 Aug; 2(2)127-37.
Score: 0.422
Microarrays--status and prospects.
Srivatsa Venkatasubbarao
Trends Biotechnol 2004 Dec; 22(12)630-7.
Score: 0.422
Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases.
D F Stern
Breast Cancer Res 2000 ; 2(3)176-83.
Score: 0.421
Proteomics in cancer research.
W Wu ... J J Kavanagh
Int J Gynecol Cancer 2002 Sep-Oct; 12(5)409-23.
Score: 0.421
Molecular portraits of breast cancer: tumour subtypes as distinct disease entities.
Therese Sørlie
Eur J Cancer 2004 Dec; 40(18)2667-75.
Score: 0.421
Tissue microarrays in urology.
Iqbal S Shergill ... Anthony R Mundy
BJU Int 2004 Jul; 94(1)22-5.
Score: 0.421
The ErbB/HER receptor protein-tyrosine kinases and cancer.
Robert Roskoski
Biochem Biophys Res Commun 2004 Jun; 319(1)1-11.
Score: 0.420
Automated quantitative volumetric breast ultrasound data-acquisition system.
J A Shipley ... B T Thomas
Ultrasound Med Biol 2005 Jul; 31(7)905-17.
Score: 0.420
Protein microarrays: a powerful tool to study cancer.
Arun Sreekumar ... Arul M Chinnaiyan
Curr Opin Mol Ther 2002 Dec; 4(6)587-93.
Score: 0.419
Quantitative in situ image analysis of apoptosis in well and poorly differentiated tumors from rat liver.
J Kong ... D P Ringer
Am J Pathol 1995 Dec; 147(6)1626-32.
Score: 0.419
Benign breast diseases, carcinoma in situ, and breast cancer risk.
C A Bodian
Epidemiol Rev 1993 ; 15(1)177-87.
Score: 0.419
Cell death induced by TNF or serum starvation is independent of ErbB receptor signaling in MCF-7 breast carcinoma cells.
M Egeblad ... M Jäättelä
Int J Cancer 2000 Jun; 86(5)617-25.
Score: 0.419
Macroresults through microarrays.
John C Rockett
Drug Discov Today 2002 Aug; 7(15)804-5.
Score: 0.418
Global profiling of gene expression in cancer using genomics and proteomics.
S M Hanash
Curr Opin Mol Ther 2001 Dec; 3(6)538-45.
Score: 0.418
Recent patents in microarrays.
Nat Biotechnol 2001 Apr; 19(4)385.
Score: 0.418
Microarrays demystified.
Jennifer Medlin
Environ Health Perspect 2004 Mar; 112(4)A222-3.
Score: 0.418
Microarrays and diagnosis.
Jay D Preston
J Am Dent Assoc 2003 Aug; 134(8)1046; author reply 1046, 1048.
Score: 0.418
Microarrays in pharmacogenomics.
James J Chen
J Biopharm Stat 2004 Aug; 14(3)535-7.
Score: 0.418
2-D or not 2-D--is there a future for 2-D gels in proteomics? Insights from the York proteomics meeting.
S Hanash
Proteomics 2001 May; 1(5)635-7.
Score: 0.418
Microarrays in disarray?
M J Davies
Trends Biotechnol 2001 May; 19(5)163.
Score: 0.418
DNA microarrays.
J P Clewley
Commun Dis Public Health 2000 Mar; 3(1)71-2.
Score: 0.418
Gene expression profiling: monitoring transcription and translation products using DNA microarrays and proteomics.
J E Celis ... T F Orntoft
FEBS Lett 2000 Aug; 480(1)2-16.
Score: 0.417
Structure-based approaches to inhibition of erbB receptors with peptide mimetics.
Alan Berezov ... Ramachandran Murali
Immunol Res 2003 ; 27(2-3)303-8.
Score: 0.417
Reverse-phase protein microarrays for tissue-based analysis.
Runa Speer ... Emanuel F Petricoin
Curr Opin Mol Ther 2005 Jun; 7(3)240-5.
Score: 0.417
Biomedical informatics for proteomics.
Mark S Boguski ... Martin W McIntosh
Nature 2003 Mar; 422(6928)233-7.
Score: 0.417
ErbB receptor tyrosine kinase inhibitors as therapeutic agents.
Neil G Anderson ... Tawhid Ahmad
Front Biosci 2002 Sep; 7()d1926-40.
Score: 0.417
Structure and function of the epidermal growth factor (EGF/ErbB) family of receptors.
Daniel J Leahy
Adv Protein Chem 2004 ; 68()1-27.
Score: 0.416
From proteomics to disease.
Kenneth H Kraemer
Nat Genet 2004 Jul; 36(7)677-8.
Score: 0.415
Genomics and proteomics.
Chris Bradfield
Chem Res Toxicol 2004 Jan; 17(1)2.
Score: 0.415
Genomics, proteomics: what's next?
James D Willett
Pharmacogenomics 2002 Nov; 3(6)727-8.
Score: 0.415
Proteomics: the next frontier.
D O Weber
Health Forum J 2000 May-Jun; 43(3)20-2.
Score: 0.415
Proteomics in a small world.
Nat Struct Biol 2002 Mar; 9(3)153.
Score: 0.415
Clinical proteomics: are we there yet?
Katie Cottingham
Anal Chem 2003 Nov; 75(21)472A-476A.
Score: 0.415
Induction of renal adenocarcinoma by a nonmutated erbB oncogene.
C A Taglienti-Sian ... H L Robinson
J Virol 1993 Feb; 67(2)1132-6.
Score: 0.415
Proteomics and bioinformatics.
Carol S Giometti
Adv Protein Chem 2003 ; 65()353-69.
Score: 0.415
Proteomics of the nucleolus.
Alison Schuldt
Nat Cell Biol 2002 Feb; 4(2)E35.
Score: 0.415
Recent patents in proteomics.
Nat Biotechnol 2001 Mar; 19(3)282.
Score: 0.415
Top-down proteomics.
Neil L Kelleher
Anal Chem 2004 Jun; 76(11)197A-203A.
Score: 0.415
The tools of proteomics.
Joseph A Loo
Adv Protein Chem 2003 ; 65()25-56.
Score: 0.415
Failed to fetch article title! Article may not be available.
Score: 0.415
What is new in proteomics? Biomarkers.
William S Hancock
J Proteome Res 2003 Sep-Oct; 2(5)457.
Score: 0.415
Proteomics.
Gerard T Hoehn ... Anthony F Suffredini
Crit Care Med 2005 Dec; 33(12 Suppl)S444-8.
Score: 0.415
Proteomics and behavior.
Katie Cottingham
J Proteome Res 2006 Feb; 5(2)229.
Score: 0.415
Podocyte proteomics.
Richard F Ransom
Contrib Nephrol 2004 ; 141()189-211.
Score: 0.415
Quantitative and automated electrophoresis in sieving media.
A Chrambach
Electrophoresis 1996 Mar; 17(3)454-64.
Score: 0.414
Regulation of early Xenopus development by ErbB signaling.
Shuyi Nie ... Chenbei Chang
Dev Dyn 2006 Feb; 235(2)301-14.
Score: 0.414
Fabrication of high quality microarrays.
Martin Dufva
Biomol Eng 2005 Dec; 22(5-6)173-84.
Score: 0.414
Cell cycle analysis and microarrays.
Stephen Cooper
Trends Genet 2002 Jun; 18(6)289-90.
Score: 0.414
Quantitative automated reagin test for syphilis.
B E McGrew ... M A Lantz
Am J Med Technol 1970 Jan; 36(1)1-7.
Score: 0.414
Prediction of cancer outcome with microarrays.
Shea N Gardner ... Michael Fernandes
Lancet 2005 May 14-20; 365(9472)1685.
Score: 0.414
The phosphoprotein StarD10 is overexpressed in breast cancer and cooperates with ErbB receptors in cellular transformation.
Monilola A Olayioye ... Jane E Visvader
Cancer Res 2004 May; 64(10)3538-44.
Score: 0.413
Risk of subsequent invasive breast cancer after breast carcinoma in situ.
F Wärnberg ... L Holmberg
Lancet 2000 Feb; 355(9205)724-5.
Score: 0.413
Proteomics delivers on promise of cancer biomarkers.
Kendall Powell
Nat Med 2003 Aug; 9(8)980.
Score: 0.412
Quantitative analysis of colorectal tissue microarrays by immunofluorescence and in situ hybridization.
A M Jubb ... K J Hillan
J Pathol 2003 Aug; 200(5)577-88.
Score: 0.412
Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis.
K S Russell ... J R Bender
Am J Physiol 1999 Dec; 277(6 Pt 2)H2205-11.
Score: 0.412
Development and application of proteomics technologies in Saccharomyces cerevisiae.
Annemieke Kolkman ... Albert J R Heck
Trends Biotechnol 2005 Dec; 23(12)598-604.
Score: 0.412
Proteomics may aid bladder cancer diagnosis.
C Sansom
Lancet Oncol 2000 Sep; 1(1)5.
Score: 0.412
Proteomics in cancer.
E V Stevens ... E C Kohn
Ann Oncol 2004 ; 15 Suppl 4()iv167-71.
Score: 0.412
Multiplexed protein analysis using antibody microarrays and label-based detection.
Brian B Haab
Methods Mol Med 2005 ; 114()183-94.
Score: 0.411
Aqua vitae: the health spas of Europe.
E G Anderson
MD 1981 Dec; 25(12)40-4.
Score: 0.411
[Surgical aqua fortis No. 8.]
A YODICE
Dia Med 1953 Oct; 25(69)1940.
Score: 0.411
[Surgical aqua fortis: No. 22.]
A YODICE
Dia Med 1956 Nov; 28(82)2576-7.
Score: 0.411
Plastic microarrays: a novel array support combining the benefits of macro- and microarrays.
Alexander Munishkin ... Alex Chenchik
Methods Mol Biol 2003 ; 224()31-54.
Score: 0.410
Treatment of in situ ductal breast cancer.
A Recht
Front Radiat Ther Oncol 1993 ; 27()52-61.
Score: 0.410
DNA microarrays: methodology, data evaluation and application in the analysis of plant defense signaling.
E Kuhn ... A Schaller
Genet Eng (N Y) 2004 ; 26()49-84.
Score: 0.410
Prognostic value of ERBB family mRNA expression in breast carcinomas.
Ivan Bièche ... Rosette Lidereau
Int J Cancer 2003 Sep; 106(5)758-65.
Score: 0.409
Quantitative MS for proteomics: teaching a new dog old tricks.
Michael J MacCoss ... Dwight E Matthews
Anal Chem 2005 Aug; 77(15)294A-302A.
Score: 0.408
Automated protein analysis.
Lancet 1969 Feb; 1(7589)297.
Score: 0.408
The interface between ErbB and non-ErbB receptors in tumor invasion: clinical implications and opportunities for target discovery.
Moulay A Alaoui-Jamali ... He Qiang
Drug Resist Updat 2003 Apr; 6(2)95-107.
Score: 0.408
Microarrays: applications and pitfalls.
Hassan M Fathallah-Shaykh
Arch Neurol 2005 Nov; 62(11)1669-72.
Score: 0.406
Family history of breast cancer, mammographic features of breast tissue, and breast cancer risk.
J Brisson
Epidemiology 1991 Nov; 2(6)440-4.
Score: 0.406
Inhibition of erbB receptor family members protects HaCaT keratinocytes from ultraviolet-B-induced apoptosis.
Davina A Lewis ... Dan F Spandau
J Invest Dermatol 2003 Mar; 120(3)483-8.
Score: 0.405
Advances in recombinant antibody microarrays.
Petra Pavlickova ... Hubert Hug
Clin Chim Acta 2004 May; 343(1-2)17-35.
Score: 0.404
Cancer proteomics: from signaling networks to tumor markers.
R J Simpson ... D S Dorow
Trends Biotechnol 2001 Oct; 19(10 Suppl)S40-8.
Score: 0.404
Proteomics in studies of signal transduction in epithelial cells.
Serhiy Souchelnytskyi
J Mammary Gland Biol Neoplasia 2002 Oct; 7(4)359-71.
Score: 0.404
Re: An automated quantitative analysis of ventilation/perfusion lung scintigrams.
M Horn
J Nucl Med 1984 Nov; 25(11)1270-1.
Score: 0.403
Automated analysis of bone marrow reticulocytes using the XE-2100 automated hematology analyzer.
Hisako Shibata ... Masayuki Hino
Acta Haematol 2004 ; 111(4)237-8.
Score: 0.402
[Model of microthrombosis and its quantitative description using automated image analysis]
L A Entsik ... V S Shinkarenko
Patol Fiziol Eksp Ter 1983 Nov-Dec; (6)74-7.
Score: 0.402
Proteomics in the analysis of prostate cancer.
Soren Naaby-Hansen ... Rainer Cramer
Methods Mol Med 2003 ; 81()277-97.
Score: 0.401
Proteomics in pancreatic disease.
Matthias Löhr ... Ralf Faissner
Pancreatology 2004 ; 4(2)67-75.
Score: 0.401
Tissue interaction mediated by neuregulin-1 and ErbB receptors regulates epithelial morphogenesis of mouse embryonic submandibular gland.
Yuji Miyazaki ... Yohki Hieda
Dev Dyn 2004 Aug; 230(4)591-6.
Score: 0.401
Dense breast tissue, mammograms and breast cancer risk.
Mayo Clin Womens Healthsource 2003 Feb; 7(2)3.
Score: 0.401
Molecular diagnostics of malignant disorders.
Michal G Rose ... Nancy Berliner
Clin Adv Hematol Oncol 2004 Oct; 2(10)650-60.
Score: 0.400
Risk of subsequent invasive breast carcinoma after in situ breast carcinoma in a population covered by national mammographic screening.
R Rawal ... K Hemminki
Br J Cancer 2005 Jan; 92(1)162-6.
Score: 0.400
The cellular response to neuregulins is governed by complex interactions of the erbB receptor family.
D J Riese ... D F Stern
Mol Cell Biol 1995 Oct; 15(10)5770-6.
Score: 0.399
Expression of erbB receptors and their ligands in breast cancer: implications to biological behavior and therapeutic response.
S S Bacus ... Y Yarden
Breast Dis 2000 ; 11()63-75.
Score: 0.399
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.
K Mirnics ... P Levitt
Mol Psychiatry 2001 May; 6(3)293-301.
Score: 0.399
Development of an autocrine neuregulin signaling loop with malignant transformation of human breast epithelial cells.
Qunfang Li ... Jeffrey A Loeb
Cancer Res 2004 Oct; 64(19)7078-85.
Score: 0.398
SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.
Yue Hu ... Shu Zheng
Breast 2005 Aug; 14(4)250-5.
Score: 0.398
Global analysis of gene expression using GeneChip microarrays.
Tong Zhu
Curr Opin Plant Biol 2003 Oct; 6(5)418-25.
Score: 0.398
HER-2 analysis in tissue microarrays of archival human breast cancer: comparison of immunohistochemistry and fluorescence in situ hybridization.
Anthony O'Grady ... Mary B Leader
Appl Immunohistochem Mol Morphol 2003 Jun; 11(2)177-82.
Score: 0.398
Proteome analysis enables separate clustering of normal breast, benign breast and breast cancer tissues.
M V Dwek ... A A Alaiya
Br J Cancer 2003 Jul; 89(2)305-7.
Score: 0.398
Comprehensive profiling of 8p11-12 amplification in breast cancer.
Véronique Gelsi-Boyer ... Max Chaffanet
Mol Cancer Res 2005 Dec; 3(12)655-67.
Score: 0.397
Structure and function of the erbB gene family.
K Toyoshima ... T Yamamoto
IARC Sci Publ 1988 ; (92)149-58.
Score: 0.397
BIBX1382BS, but not AG1478 or PD153035, inhibits the ErbB kinases at different concentrations in intact cells.
M Egeblad ... M Jäättelä
Biochem Biophys Res Commun 2001 Feb; 281(1)25-31.
Score: 0.397
Take your partners, please--signal diversification by the erbB family of receptor tyrosine kinases.
R J Daly
Growth Factors 1999 ; 16(4)255-63.
Score: 0.397
Mathematical morphologic segmentation dedicated to quantitative immunohistochemistry.
S Schüpp ... D Bloyet
Anal Quant Cytol Histol 2001 Aug; 23(4)257-67.
Score: 0.396
Disabling receptor ensembles with rationally designed interface peptidomimetics.
Alan Berezov ... Ramachandran Murali
J Biol Chem 2002 Aug; 277(31)28330-9.
Score: 0.396
Oral contraceptives and risk of breast cancer in women with a family history of breast cancer.
L R Kirkland
JAMA 2001 Jan; 285(1)39, 40.
Score: 0.396
Proteomics: current technologies and applications in neurological disorders and toxicology.
M Fountoulakis
Amino Acids 2001 Dec; 21(4)363-81.
Score: 0.396
Site-directed irreversible inhibitors of the erbB family of receptor tyrosine kinases as novel chemotherapeutic agents for cancer.
D W Fry
Anticancer Drug Des 2000 Feb; 15(1)3-16.
Score: 0.396
Proteomics in nutrition and health.
Martin Kussmann ... Laurent B Fay
Comb Chem High Throughput Screen 2005 Dec; 8(8)679-96.
Score: 0.396
Parallel analysis of gene copy number and expression using cDNA microarrays.
Jonathan R Pollack
Methods Mol Biol 2003 ; 224()89-97.
Score: 0.395
Microarray: a versatile platform for high-throughput functional proteomics.
Yi Hu ... Shao Q Yao
Comb Chem High Throughput Screen 2006 Mar; 9(3)203-12.
Score: 0.395
Genomewide gene expression analysis using cDNA microarrays.
Chuang Fong Kong ... David Bowtell
Methods Mol Med 2002 ; 68()195-204.
Score: 0.395
A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples.
S-F Chin ... C Caldas
Mol Pathol 2003 Oct; 56(5)275-9.
Score: 0.394
Tissue microarrays for predictive molecular pathology.
G Sauter ... M Mirlacher
J Clin Pathol 2002 Aug; 55(8)575-6.
Score: 0.394
Tissue microarrays in drug discovery.
Guido Sauter ... Kenneth Hillan
Nat Rev Drug Discov 2003 Dec; 2(12)962-72.
Score: 0.394
G1 cell cycle arrest due to the inhibition of erbB family receptor tyrosine kinases does not require the retinoblastoma protein.
Andrea J Gonzales ... David W Fry
Exp Cell Res 2005 Feb; 303(1)56-67.
Score: 0.394
From correlation to causality: microarrays, cancer, and cancer treatment.
Geraldine M O'Neill ... Erica A Golemis
Biotechniques 2003 Mar; Suppl()64-71.
Score: 0.391
Automated perimetry.
D A Springer ... L J Alexander
Am J Optom Physiol Opt 1978 Oct; 55(10)725-7.
Score: 0.390
Breast cancer: family under stress.
B Borwell
Nurs Times 1996 Nov 13-19; 92(46)52-3.
Score: 0.390
Breast cancer as a family disease.
C Ott
Nebr Nurse 1997 Aug; 30(3)27.
Score: 0.390
Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder.
N H Chow ... H S Liu
Clin Cancer Res 2001 Jul; 7(7)1957-62.
Score: 0.390
[Proteomics in ophthalmology]
Jiang Guo ... Minbin Yu
Yan Ke Xue Bao 2003 Jun; 19(2)67-70.
Score: 0.389
Structural requirements for ErbB2 transactivation.
E Penuel ... M X Sliwkowski
Semin Oncol 2001 Dec; 28(6 Suppl 18)36-42.
Score: 0.389
Quantitative analysis of in situ hybridization histochemistry.
A L Gundlach ... R D O'Shea
Int Rev Neurobiol 2002 ; 47()135-70.
Score: 0.389
Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis.
Anthony McCabe ... David L Rimm
J Natl Cancer Inst 2005 Dec; 97(24)1808-15.
Score: 0.388
SPS' Digest: the Swiss Proteomics Society selection of proteomics articles.
Christine Hoogland ... Jean-Daniel Tissot
Proteomics 2005 Aug; 5(12)3045-7.
Score: 0.388
Proteomics of breast cancer: enhanced expression of CK19 in HER-2/neu-positive tumours.
L K Tai ... E S C Koay
Ann Acad Med Singapore 2004 Sep; 33(5 Suppl)S17-8.
Score: 0.388
An automated quantitative assay for uronic acids.
N Blumenkrantz ... G Asboe-Hansen
Biochem Med 1974 Sep; 11(1)60-6.
Score: 0.388
An automated procedure for quantitative determination of hydroxyproline.
N Blumenkrantz ... G Asboe-Hansen
Clin Biochem 1974 Sep; 7(3)251-7.
Score: 0.388
Prediction of cancer outcome with microarrays.
Norio Iizuka ... Masaaki Oka
Lancet 2005 May 14-20; 365(9472)1683-4; author reply 1684-5.
Score: 0.387
Microarrays in cancer: moving from hype to clinical reality.
Neil Winegarden
Lancet 2003 Nov; 362(9394)1428.
Score: 0.387
Proteomic profiling from human samples: the body fluid alternative.
S Kennedy
Toxicol Lett 2001 Mar; 120(1-3)379-84.
Score: 0.387
Gene diagnostics provide new insights into breast cancer prognosis and therapy.
C C Benz ... K S Zänker
Gene 1995 Jun; 159(1)3-7.
Score: 0.387
Lipid rafts in neuregulin signaling at synapses.
Xiao-Li Yang ... Lin Mei
Life Sci 2004 Oct; 75(21)2495-504.
Score: 0.387
How diagnosis with microarrays can help cancer patients.
J R Masters ... S R Lakhani
Nature 2000 Apr; 404(6781)921.
Score: 0.387
Refinements in breast cancer risk analysis.
P T Kelly
Arch Surg 1981 Mar; 116(3)364-5.
Score: 0.386
The ErbB receptors and their ligands in cancer: an overview.
N Normanno ... D S Salomon
Curr Drug Targets 2005 May; 6(3)243-57.
Score: 0.386
[Research development of proteomics in pancreatic cancer]
Li Ning ... Yu-pei Zhao
Zhongguo Yi Xue Ke Xue Yuan Xue Bao 2005 Oct; 27(5)640-3.
Score: 0.386
Oral contraceptives and risk of breast cancer in women with a family history of breast cancer.
F Aslam ... H Rashid
JAMA 2001 Jan; 285(1)39-40.
Score: 0.385
An automated system for the quantitative determination of proteolytic enzymes using azocasein.
G G Hazen ... J A Hubicki
Ann N Y Acad Sci 1965 Nov; 130(2)761-8.
Score: 0.385
Clinical proteomics: new promises for early cancer detection.
Sara M Mariani
MedGenMed 2003 Apr; 5(2)23.
Score: 0.385
[Another aspect of the effectiveness of Aqua Pik]
D D Zinner ... J M Jablon
Dent Cadmos 1969 Jan; 37(1)129-31.
Score: 0.385
[Surgical aqua fortis: case No. 21.]
A YODICE
Dia Med 1956 Sep; 28(70)2161-2.
Score: 0.385
[BLINDNESS AND "AQUA DISTILLATA".]
C WANNEBROUCQ ... A BLERVACQUE
Bull Soc Ophtalmol Fr 1964 Sep; 64()696-9.
Score: 0.385
An aqua birth concept--midwives' and parent's perspectives.
L Ford ... D Garland